Table 1.

Clinical and biological characteristics of patient cohort.

Clinical Information		Frequency (n)		Percentage (%)
Gender	Female	29		43.3
	Male	38		56.7
Age	≤65	24		35.8
	>65	43		64.2
Diagnosis	MBLhi	10		14.9
	CLL	57		85.1
CLL status	Stable/constant	42		73.7
	Progression	15		26.3
Binet stage	A	54		80.6
	B	6		9
	C	7		10.4
Rai stage	0	45		67.2
	I	5		7.5
	II	10		14.9
	III	1		1.5
	IV	6		9
Treatment status	Previously to 1st line	9		60
	Time from 1st line	5		33.3
IGHV gene status	Mutated	45		67.2
	Unmutated	22		32.8
Cytogenetic	Normal	24		35.8
	Abnormal	43		64.2
Total		67		100